VIJAYA DIAGNOSTIC CENTRE LIMITED Financials Vijaya Diagnostic Centre Limited
Equities
VIJAYA
INE043W01024
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 702.9 INR | +1.66% |
|
+4.47% | +4.03% |
| Feb. 06 | Vijaya Diagnostic Centre's Consolidated Profit Jumps in Fiscal Q3 | MT |
| Feb. 06 | Transcript : Vijaya Diagnostic Centre Limited, Q3 2024 Earnings Call, Feb 06, 2024 |
Valuation
| Fiscal Period: März | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 44,676 | 39,940 | 71,939 | - | - |
| Enterprise Value (EV) 1 | 44,676 | 38,922 | 70,031 | 68,900 | 67,588 |
| P/E ratio | 41 x | 47.4 x | 60.9 x | 49 x | 39.5 x |
| Yield | 0.23% | 0.26% | 0.22% | 0.23% | 0.29% |
| Capitalization / Revenue | 9.66 x | 8.7 x | 13.3 x | 10.8 x | 9.32 x |
| EV / Revenue | 9.66 x | 8.48 x | 12.9 x | 10.4 x | 8.75 x |
| EV / EBITDA | 21.9 x | 21.4 x | 32.1 x | 25.3 x | 21 x |
| EV / FCF | 125 x | 97.9 x | -81.7 x | 45.5 x | 29.6 x |
| FCF Yield | 0.8% | 1.02% | -1.22% | 2.2% | 3.37% |
| Price to Book | 9.54 x | 7.33 x | 11.3 x | 9.51 x | 7.95 x |
| Nbr of stocks (in thousands) | 101,966 | 102,071 | 102,346 | - | - |
| Reference price 2 | 438.2 | 391.3 | 702.9 | 702.9 | 702.9 |
| Announcement Date | 5/26/22 | 5/29/23 | - | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: März | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | 4,624 | 4,592 | 5,422 | 6,655 | 7,721 |
| EBITDA 1 | - | 2,037 | 1,820 | 2,182 | 2,722 | 3,211 |
| EBIT 1 | - | 1,510 | 1,203 | 1,595 | 2,005 | 2,439 |
| Operating Margin | - | 32.66% | 26.2% | 29.42% | 30.12% | 31.6% |
| Earnings before Tax (EBT) 1 | - | 1,474 | 1,135 | 1,561 | 1,964 | 2,443 |
| Net income 1 | 842.6 | 1,097 | 846.3 | 1,179 | 1,473 | 1,828 |
| Net margin | - | 23.72% | 18.43% | 21.74% | 22.14% | 23.68% |
| EPS 2 | 8.260 | 10.69 | 8.260 | 11.53 | 14.33 | 17.78 |
| Free Cash Flow 1 | - | 356.5 | 397.7 | -856.7 | 1,513 | 2,280 |
| FCF margin | - | 7.71% | 8.66% | -15.8% | 22.74% | 29.53% |
| FCF Conversion (EBITDA) | - | 17.5% | 21.85% | - | 55.59% | 71.01% |
| FCF Conversion (Net income) | - | 32.5% | 46.99% | - | 102.7% | 124.7% |
| Dividend per Share 2 | - | 1.000 | 1.000 | 1.525 | 1.600 | 2.050 |
| Announcement Date | 6/5/21 | 5/26/22 | 5/29/23 | - | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: March | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 1,108 | 1,162 | 1,044 | 1,207 | 1,131 | 1,210 | 1,210 | 1,369 | 1,321 | 1,493 |
| EBITDA 1 | - | 478.3 | 478.6 | 398.9 | 487.4 | 442.9 | 491.1 | 481.2 | 553.5 | 520.2 | 608 |
| EBIT | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) | - | - | - | 237.2 | - | - | - | - | - | - | - |
| Net income 1 | 277.1 | 252.9 | - | 174.5 | 233.3 | 163.6 | 274.9 | 263.8 | 311 | 277 | 308 |
| Net margin | - | 22.83% | - | 16.72% | 19.32% | 14.47% | 22.72% | 21.8% | 22.72% | 20.97% | 20.63% |
| EPS | 2.700 | 2.460 | - | 1.700 | 2.270 | 1.600 | - | - | - | - | 3.000 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/8/21 | 2/4/22 | 5/26/22 | 8/9/22 | 11/10/22 | 2/13/23 | 5/29/23 | 8/9/23 | - | - | - |
1INR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | - | - | 1,019 | 1,908 | 3,039 | 4,351 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | - | 357 | 398 | -857 | 1,513 | 2,280 |
| ROE (net income / shareholders' equity) | - | 26.5% | 16.7% | 19.5% | 20.5% | 21.2% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - |
| Book Value Per Share 2 | - | 45.90 | 53.40 | 62.20 | 73.90 | 88.40 |
| Cash Flow per Share | - | - | - | - | - | - |
| Capex 1 | - | 1,223 | 1,248 | 2,537 | 895 | 875 |
| Capex / Sales | - | 26.46% | 27.19% | 46.79% | 13.45% | 11.33% |
| Announcement Date | 6/5/21 | 5/26/22 | 5/29/23 | - | - | - |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
702.9
INR
Average target price
678.6
INR
Spread / Average Target
-3.46%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +4.03% | 863M | |
| -17.89% | 8.25B | |
| +39.20% | 3.58B | |
| -39.11% | 2.46B | |
| -8.06% | 2.46B | |
| -7.35% | 2.38B | |
| -19.01% | 1.55B | |
| -40.66% | 1.21B | |
| +7.56% | 1.11B | |
| -15.34% | 1.03B |
- Stock Market
- Equities
- VIJAYA Stock
- Financials Vijaya Diagnostic Centre Limited
